Skip to main content
Watch Insiders
FDMTHealthcare

4D Molecular Therapeutics Inc (FDMT) Insider Trading

In the last 90 days, 2 4D Molecular Therapeutics Inc (FDMT) insiders reported no open-market purchases and 9 sales totaling $3,143,585. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 16, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 16, 2026Scott BizilyChief Legal OfficerSale1,635$12.84$20,993
Oct 5, 2026David KirnSee RemarksSale58,333$12.92$753,937
Sep 16, 2026Scott BizilyChief Legal OfficerSale1,635$13.65$22,318
Sep 14, 2026David KirnSee RemarksSale58,333$13.90$811,004
Sep 1, 2026Scott BizilyChief Legal OfficerSale584$14.00$8,176
Aug 19, 2026David KirnSee RemarksSale69,076$15.75$1,088,272
Aug 17, 2026Scott BizilyChief Legal OfficerSale3,270$12.10$39,567
Aug 4, 2026David KirnSee RemarksSale26,842$10.23$274,596
Aug 3, 2026David KirnSee RemarksSale12,415$10.05$124,722
Jul 10, 2026David KirnSee RemarksSale58,333$12.64$737,411
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

FDMT insider trading FAQ

Are FDMT insiders buying or selling?
Over the last 90 days, FDMT insiders were net sellers, reporting $0.00 of open-market purchases and $3,143,585 of sales.
When was the last FDMT insider purchase?
No open-market insider purchase of 4D Molecular Therapeutics Inc stock was reported in the last 90 days.
Where does FDMT insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that 4D Molecular Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.